345567002	345567002	CD	B-NP	O
|	|	NN	I-NP	O
NTH	NTH	NN	I-NP	O
|	|	NN	I-NP	O
88703146	88703146	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4429316	4429316	CD	B-NP	O
|	|	CC	I-NP	O
6/12/2005	6/12/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CAD	CAD	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/20/2005	4/20/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/1/2005	11/1/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O
WERRIES	WERRIES	NNS	I-NP	O
,	,	,	O	O
ORVAL	ORVAL	NNP	B-NP	O
705-95-33-2	705-95-33-2	CD	I-NP	O
As	As	IN	B-SBAR	O
Ron	Ron	NNP	B-NP	O
Son	Son	NNP	I-NP	O
Sa	Sa	NNP	I-NP	O
Lo	Lo	NNP	I-NP	O
Ford	Ford	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
2/24/05	2/24/05	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HAHM	HAHM	NNP	B-NP	O
,	,	,	O	O
ISRAEL	ISRAEL	NNP	B-NP	O
G.	G.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/4/05	6/4/05	CD	B-NP	O
by	by	IN	B-PP	O
HARAJLY	HARAJLY	NN	B-NP	O
,	,	,	O	O
BOYCE	BOYCE	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ECASA	ECASA	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	O
21831848	21831848	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
DEFINITE	DEFINITE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Aspirin	Aspirin	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
GI	GI	NNP	B-NP	O
BLEED	BLEED	NNP	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Its	Its	PRP$	B-NP	O
ok	ok	NN	I-NP	O
.	.	.	O	O

DILTIAZEM	DILTIAZEM	NN	B-NP	B-protein
30	30	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/4/05	6/4/05	CD	B-NP	O
by	by	IN	B-PP	O
WHOOLEY	WHOOLEY	NNP	B-NP	O
,	,	,	O	O
LAVERN	LAVERN	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
We	We	PRP	B-NP	O
know	know	VBP	B-VP	O
.	.	.	O	O

LISINOPRIL	LISINOPRIL	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/29/05	2/29/05	CD	B-NP	O
by	by	IN	B-PP	O
FUHRMEISTER	FUHRMEISTER	NNP	B-NP	O
,	,	,	O	O
DAMON	DAMON	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
HTN	HTN	NN	B-NP	B-protein
NITROGLYCERIN	NITROGLYCERIN	NN	I-NP	I-protein
1/150	1/150	CD	B-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	B-DNA
0.4	0.4	CD	I-NP	I-DNA
MG	MG	NN	I-NP	I-DNA
-RRB-	-RRB-	HYPH	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
TAB	TAB	NN	I-NP	I-DNA
SL	SL	NN	I-NP	I-DNA
q5min	q5min	NN	I-NP	I-DNA
x	x	SYM	B-NP	I-DNA
3	3	CD	I-NP	I-DNA
PRN	PRN	NN	I-NP	I-DNA
chest	chest	NN	I-NP	I-DNA
pain	pain	NN	I-NP	I-DNA
ZOCOR	ZOCOR	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
20	20	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

CLOPIDOGREL	CLOPIDOGREL	NN	B-NP	O
75	75	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
June	June	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/4/05	6/4/05	CD	B-NP	O
by	by	IN	B-PP	O
NEAR	NEAR	NN	B-NP	B-protein
,	,	,	O	O
PERRY	PERRY	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
NAPROXEN	NAPROXEN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
89016494	89016494	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CLOPIDOGREL	CLOPIDOGREL	NNP	B-NP	O
BISULFATE	BISULFATE	NNP	I-NP	O
&	&	CC	I-NP	O
NAPROXEN	NAPROXEN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
September	September	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/24/05	2/24/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
htn	htn	NN	B-NP	O
GLIPIZIDE	GLIPIZIDE	NN	I-NP	O
5.0	5.0	CD	I-NP	O
MG	MG	NN	I-NP	O
QAM	QAM	NN	I-NP	O
;	;	:	O	O
2.5	2.5	CD	B-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
PO	PO	NN	I-NP	O
5.0	5.0	CD	I-NP	O
MG	MG	NN	I-NP	O
QAM	QAM	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
METFORMIN	METFORMIN	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Eldridge	Eldridge	NNP	I-NP	O
Jain	Jain	NNP	I-NP	O
1/12/2005	1/12/2005	CD	I-NP	O
2	2	CD	I-NP	O
:	:	:	O	O
24	24	CD	B-NP	O
PM	PM	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Dewitt	Dewitt	NNP	I-NP	O
Dudycha	Dudycha	NNP	I-NP	O
8/12/05	8/12/05	CD	I-NP	O
at	at	IN	B-PP	O
11	11	CD	B-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
am	am	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
,	,	,	O	O
Codeine	Codeine	NN	B-NP	O
,	,	,	O	O
HYDROMORPHONE	HYDROMORPHONE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
,	,	,	O	O
CAPTOPRIL	CAPTOPRIL	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Chest	Chest	NNP	B-NP	O
Pain	Pain	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CAD	CAD	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Hyperlipidemia	Hyperlipidemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Diabetes	Diabetes	NNP	I-NP	O
Mellitus	Mellitus	NNP	I-NP	O
Type	Type	NNP	I-NP	O
2	2	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PUD	PUD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
peptic	peptic	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Hx	Hx	NN	I-NP	O
GI	GI	NN	I-NP	O
bleeding	bleed	VBG	B-VP	O
-LRB-	-LRB-	NN	B-NP	O
H/O	H/O	NN	I-NP	O
upper	upper	JJ	I-NP	O
GI	GI	NN	I-NP	O
bleeding	bleed	VBG	B-VP	O
-RRB-	-RRB-	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sestamibi	Sestamibi	NNP	I-NP	O
-	-	HYPH	B-NP	O
adenosine	adenosine	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
Cardiac	Cardiac	JJ	I-NP	O
echocardiograph	echocardiograph	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
Chest	Chest	NNP	B-NP	O
,	,	,	O	O
shoulder	shoulder	NN	B-NP	O
pain	pain	NN	I-NP	O
*	*	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
43y	43y	CD	B-NP	O
diabetic	diabetic	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
3vD	3vD	NN	B-NP	O
,	,	,	O	O
discharged	discharge	VBN	B-VP	O
from	from	IN	B-PP	O
MCH	MCH	NN	B-NP	B-protein
on	on	IN	B-PP	O
4/11	4/11	NN	B-NP	O
after	after	IN	B-PP	O
3vCABG	3vCABG	NN	B-NP	O
,	,	,	O	O
initially	initially	RB	B-VP	O
manifested	manifest	VBN	I-VP	O
as	as	IN	B-PP	O
chest	chest	NN	B-NP	O
tightness	tightness	NN	I-NP	O
and	and	CC	O	O
L	L	NN	B-NP	B-protein
shoulder	shoulder	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

CABG	CABG	NN	B-NP	B-protein
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
complex	complex	JJ	B-NP	O
anatomy	anatomy	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LIMA-LAD	LIMA-LAD	NN	I-NP	O
,	,	,	O	O
LRad-Ao-OM1	LRad-Ao-OM1	NN	B-NP	O
,	,	,	O	O
LVB/SVG-PDA	LVB/SVG-PDA	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
with	with	IN	B-PP	O
small-caliber	small-caliber	JJ	B-NP	O
grafts	graft	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
postop	postop	JJ	I-NP	O
course	course	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
MI	MI	NN	B-NP	O
and	and	CC	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

Mr.	Mr.	NNP	B-NP	O
Meisch	Meisch	NNP	I-NP	O
currently	currently	RB	B-ADVP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
12	12	CD	B-NP	O
hours	hour	NNS	I-NP	O
continuous	continuous	JJ	B-NP	O
6/10	6/10	CD	I-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
sharp	sharp	JJ	B-NP	O
L	L	NN	I-NP	O
shoulder	shoulder	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
relieved	relieve	VBN	I-VP	O
by	by	IN	B-PP	O
NTG/narcotic	NTG/narcotic	NNP	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
and	and	CC	O	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
suggested	suggest	VBN	B-VP	O
against	against	IN	B-PP	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
suspicion	suspicion	NN	B-NP	O
of	of	IN	B-PP	O
pericarditis	pericarditis	NN	B-NP	O
/	/	SYM	B-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
history	history	NN	B-NP	O
and	and	CC	I-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
and	and	CC	O	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
in	in	IN	B-PP	O
-	-	HYPH	B-NP	O
house	house	NN	I-NP	O
but	but	CC	O	O
noted	note	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypervolemic	hypervolemic	JJ	B-ADJP	O
with	with	IN	B-PP	O
JVP	JVP	NN	B-NP	O
12cm	12cm	CD	I-NP	O
,	,	,	O	O
clear	clear	JJ	B-NP	O
lungs	lung	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
s4	s4	NN	B-NP	B-protein
gallop	gallop	NN	I-NP	I-protein
without	without	IN	B-PP	I-protein
rub	rub	NN	B-NP	I-protein
on	on	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
displaying	display	VBG	B-VP	O
mild	mild	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
sestamibi	sestamibi	AFX	I-NP	O
-	-	HYPH	I-NP	O
adenosine	adenosine	NN	I-NP	O
stress	stress	NN	I-NP	O
study	study	NN	I-NP	O
displayed	display	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
inferobasal	inferobasal	JJ	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
reversible	reversible	JJ	B-NP	O
perfusion	perfusion	NN	I-NP	O
defect	defect	NN	I-NP	O
without	without	IN	B-PP	O
wall	wall	NN	B-NP	O
motion	motion	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
mildly	mildly	RB	I-NP	O
dilated	dilate	VBN	I-NP	O
left	left	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
with	with	IN	B-PP	O
inferior	inferior	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
free	free	JJ	B-ADJP	O
of	of	IN	B-PP	O
effusion	effusion	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-NP	O
or	or	CC	I-NP	O
improved	improved	JJ	I-NP	O
verses	verse	NNS	I-NP	O
similar	similar	JJ	B-NP	O
tests	test	NNS	I-NP	O
performed	perform	VBN	B-VP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Mr.	Mr.	NNP	B-NP	O
Constantino	Constantino	NNP	I-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
20mg	20mg	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
IV	IV	CD	I-NP	O
x1	x1	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
20mg	20mg	NN	B-NP	O
Lasix	Lasix	NNP	I-NP	O
PO	PO	NNP	I-NP	O
x1	x1	NN	I-NP	O
to	to	TO	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	B-DNA
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
had	have	VBD	B-VP	O
complety	complety	NN	B-NP	O
resolved	resolve	VBN	B-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
nearly	nearly	RB	B-ADJP	O
euvolemic	euvolemic	JJ	I-ADJP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
develop	develop	VB	I-VP	O
a	a	DT	B-NP	O
bad	bad	JJ	I-NP	O
taste	taste	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
mouth	mouth	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
captopril	captopril	NN	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-VP	O
lisinopril	lisinopril	VB	I-VP	O
with	with	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Parone	Parone	NNP	I-NP	O
agreed	agree	VBD	B-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
a	a	DT	B-NP	O
consultant	consultant	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
WC	WC	NN	I-NP	O
department	department	NN	I-NP	O
of	of	IN	B-PP	O
Psychiatry	Psychiatry	NN	B-NP	O
for	for	IN	B-PP	O
numerous	numerous	JJ	B-NP	O
issues	issue	NNS	I-NP	O
within	within	IN	B-PP	O
his	his	PRP$	B-NP	O
personal	personal	JJ	I-NP	O
life	life	NN	I-NP	O
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
causing	cause	VBG	I-VP	O
him	him	PRP	B-NP	O
distress	distress	NN	B-NP	O
.	.	.	O	O

Formal	Formal	JJ	B-NP	O
recommendations	recommendation	NNS	I-NP	O
from	from	IN	B-PP	O
psychiatry	psychiatry	NN	B-NP	O
after	after	IN	B-PP	O
extended	extend	VBN	B-NP	O
conversions	conversion	NNS	I-NP	O
with	with	IN	B-PP	O
Mr.	Mr.	NNP	B-NP	O
Knapick	Knapick	NNP	I-NP	O
include	include	VBP	B-VP	O
a	a	DT	B-NP	O
referral	referral	NN	I-NP	O
to	to	TO	B-PP	O
Family	Family	NNP	B-NP	O
Services	Services	NNP	I-NP	O
at	at	IN	B-PP	O
Pin	Pin	NNP	B-NP	B-protein
Chiblan	Chiblan	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
couple	couple	NN	B-NP	O
's	's	POS	B-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
him	him	PRP	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
referral	referral	NN	B-NP	O
to	to	TO	B-PP	O
VGMC	VGMC	NN	B-NP	O
outpatient	outpatient	NN	I-NP	O
psychiatry	psychiatry	NN	I-NP	O
for	for	IN	B-PP	O
individual	individual	JJ	B-NP	O
and	and	CC	I-NP	O
possibly	possibly	RB	I-NP	O
pharmacologic	pharmacologic	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Consider	Consider	VB	B-VP	O
Cardiac	Cardiac	JJ	B-NP	O
Rehabilitation	Rehabilitation	NN	I-NP	O
program	program	NN	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BURKEL	BURKEL	NN	B-NP	O
,	,	,	O	O
RAPHAEL	RAPHAEL	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DO98	DO98	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2/24/05	2/24/05	CD	I-NP	O
@	@	SYM	O	O
02	02	CD	B-NP	O
:	:	SYM	I-NP	O
20	20	CD	I-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

